Who
Julie McHugh
Director
Company insider
Files Form 4 as: Director, Ironwood Pharmaceuticals; Director, Lantheus Holdings; Director, Evelo Biosciences; Director, Aerie Pharmaceuticals; Director, Trevena; Director, EPIRUS Biopharmaceuticals; Director, Viropharma; Chief Operating Officer, Endo Health Solutions.
In numbers
- Trades disclosed
- 119
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $2.3M
- Companies
- 8
- Companies where not an officer
- 7
- First trade
- 23 Feb 2011
- Last trade
- 16 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $80K21,571 at $3.73 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $80K21,571 at $3.73 | filing |
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 9 Jun 2025filed 11 Jun 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $424K5,192 at $81.62 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,543 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,537 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —24,311 at $0.00 | filing |
| 10 Jun 2024filed 12 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $143K22,766 at $6.29 | filing |
| 28 May 2024filed 30 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $196K2,500 at $78.50 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,853 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,635 at $0.00 | filing |
| 20 Jun 2023filed 22 Jun 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,350 at $0.00 | filing |
| 8 Jun 2023filed 12 Jun 2023 | Evelo Biosciencesoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 11 May 2023filed 15 May 2023 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,798 at $0.00 | filing |
| 11 May 2023filed 15 May 2023 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,012 at $0.00 | filing |
| 21 Nov 2022filed 21 Nov 2022 | Aerie Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | $15K7,800 at $1.98 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.